Palo Alto Investors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.2M | Buy |
62,809
+4,623
| +8% | +$2.3M | 5.7% | 5 |
|
|
2025
Q4 | $28.4M | Hold |
58,186
| – | – | 3.95% | 9 |
|
|
2025
Q3 | $24.4M | Sell |
58,186
-37,296
| -39% | -$12.5M | 4.51% | 7 |
|
|
2025
Q2 | $27.4M | Sell |
95,482
-9,746
| -9% | -$2.91M | 5.84% | 5 |
|
|
2025
Q1 | $32.4M | Sell |
105,228
-50,486
| -32% | -$17.3M | 6.18% | 5 |
|
|
2024
Q4 | $54.9M | Sell |
155,714
-27,532
| -15% | -$10.1M | 8.51% | 4 |
|
|
2024
Q3 | $65.7M | Sell |
183,246
-83,668
| -31% | -$28.3M | 8.53% | 4 |
|
|
2024
Q2 | $85M | Sell |
266,914
-845
| -0.3% | -$224K | 9.85% | 4 |
|
|
2024
Q1 | $61.5M | Sell |
267,759
-128,025
| -32% | -$28.9M | 6.94% | 5 |
|
|
2023
Q4 | $87M | Sell |
395,784
-180,123
| -31% | -$41.5M | 7.84% | 5 |
|
|
2023
Q3 | $130M | Sell |
575,907
-51,607
| -8% | -$11.9M | 12.31% | 3 |
|
|
2023
Q2 | $139M | Hold |
627,514
| – | – | 11.19% | 2 |
|
|
2023
Q1 | $141M | Buy |
627,514
+2,100
| +0.3% | +$518K | 11.64% | 3 |
|
|
2022
Q4 | $174M | Sell |
625,414
-8,120
| -1% | -$2.05M | 14.83% | 2 |
|
|
2022
Q3 | $133M | Sell |
633,534
-1,272
| -0.2% | -$284K | 10.49% | 2 |
|
|
2022
Q2 | $150M | Sell |
634,806
-18,273
| -3% | -$3.71M | 13.04% | 2 |
|
|
2022
Q1 | $117M | Sell |
653,079
-34,127
| -5% | -$6.5M | 9.06% | 4 |
|
|
2021
Q4 | $148M | Hold |
687,206
| – | – | 9.49% | 4 |
|
|
2021
Q3 | $127M | Hold |
687,206
| – | – | 7.66% | 5 |
|
|
2021
Q2 | $123M | Hold |
687,206
| – | – | 6.79% | 6 |
|
|
2021
Q1 | $115M | Sell |
687,206
-98,200
| -13% | -$16.4M | 6.55% | 5 |
|
|
2020
Q4 | $119M | Hold |
785,406
| – | – | 6.25% | 7 |
|
|
2020
Q3 | $79.3M | Buy |
785,406
+19,000
| +2% | +$2.08M | 4.35% | 7 |
|
|
2020
Q2 | $92.7M | Sell |
766,406
-110,169
| -13% | -$12.4M | 5.57% | 7 |
|
|
2020
Q1 | $83.1M | Sell |
876,575
-412,327
| -32% | -$39.2M | 6.96% | 5 |
|
|
2019
Q4 | $114M | Sell |
1,288,902
-135,499
| -10% | -$11.9M | 6.25% | 6 |
|
|
2019
Q3 | $114M | Sell |
1,424,401
-128,391
| -8% | -$10.3M | 7.57% | 4 |
|
|
2019
Q2 | $121M | Sell |
1,552,792
-79,233
| -5% | -$7.41M | 5.89% | 7 |
|
|
2019
Q1 | $192M | Hold |
1,632,025
| – | – | 7.99% | 4 |
|
|
2018
Q4 | $178M | Buy |
1,632,025
+6,791
| +0.4% | +$787K | 9.46% | 3 |
|
|
2018
Q3 | $208M | Hold |
1,625,234
| – | – | 8.4% | 3 |
|
|
2018
Q2 | $184M | Buy |
1,625,234
+2,603
| +0.2% | +$286K | 7.35% | 4 |
|
|
2018
Q1 | $182M | Buy |
1,622,631
+16,381
| +1% | +$2.08M | 7.8% | 4 |
|
|
2017
Q4 | $238M | Sell |
1,606,250
-156,400
| -9% | -$19.9M | 10.23% | 2 |
|
|
2017
Q3 | $207M | Sell |
1,762,650
-104,665
| -6% | -$13.4M | 8.7% | 4 |
|
|
2017
Q2 | $242M | Sell |
1,867,315
-16,000
| -0.8% | -$2M | 11.31% | 3 |
|
|
2017
Q1 | $255M | Buy |
1,883,315
+14,500
| +0.8% | +$2.2M | 12.05% | 1 |
|
|
2016
Q4 | $268M | Buy |
1,868,815
+105,357
| +6% | +$13.5M | 15.29% | 1 |
|
|
2016
Q3 | $208M | Buy |
1,763,458
+44,800
| +3% | +$5.38M | 12.1% | 2 |
|
|
2016
Q2 | $182M | Buy |
1,718,658
+193,004
| +13% | +$21.5M | 13.75% | 2 |
|
|
2016
Q1 | $170M | Buy |
1,525,654
+7,000
| +0.5% | +$886K | 13.2% | 2 |
|
|
2015
Q4 | $238M | Sell |
1,518,654
-5,600
| -0.4% | -$815K | 13.24% | 3 |
|
|
2015
Q3 | $200M | Buy |
1,524,254
+84,326
| +6% | +$13.5M | 9.62% | 4 |
|
|
2015
Q2 | $250M | Buy |
1,439,928
+10,000
| +0.7% | +$1.8M | 11.14% | 1 |
|
|
2015
Q1 | $247M | Buy |
1,429,928
+26,800
| +2% | +$4.09M | 12.19% | 1 |
|
|
2014
Q4 | $182M | Buy |
1,403,128
+104,300
| +8% | +$13.4M | 10.67% | 1 |
|
|
2014
Q3 | $167M | Buy |
1,298,828
+85,000
| +7% | +$8.76M | 12.48% | 1 |
|
|
2014
Q2 | $107M | Buy |
1,213,828
+112,800
| +10% | +$10.8M | 8% | 2 |
|
|
2014
Q1 | $104M | Buy |
1,101,028
+5,600
| +0.5% | +$573K | 8.56% | 4 |
|
|
2013
Q4 | $124M | Buy |
1,095,428
+31,986
| +3% | +$2.88M | 11.56% | 2 |
|
|
2013
Q3 | $83.9M | Buy |
1,063,442
+162,664
| +18% | +$11.9M | 8.79% | 3 |
|
|
2013
Q2 | $59.3M | Buy |
+900,778
| New | +$58M | 7% | 4 |
|
Other funds holding UTHR
ACA
VPM
VCM
Palo Alto Investors's UTHR Position: Q1 2026 in Review
Palo Alto Investors increased its United Therapeutics (UTHR) stake by 7.9% in Q1 2026, buying an estimated $2.3M and bringing the position to 62,809 shares worth $37.2M. The position accounts for 5.7% of the portfolio, ranked #5.
Palo Alto Investors first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. The position peaked at $268M in Q4 2016. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.
- Palo Alto Investors held 62,809 shares of United Therapeutics worth $37.2M as of Q1 2026.
- Palo Alto Investors bought 4,623 United Therapeutics shares in Q1 2026, an estimated $2.3M.
- United Therapeutics made up 5.7% of Palo Alto Investors's portfolio in Q1 2026, its #5 holding.
- Palo Alto Investors first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Palo Alto Investors's United Therapeutics position peaked at $268M in Q4 2016.
- 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.
Based on Palo Alto Investors's 13F filing for Q1 2026, filed 15 May 2026.